AUSTIN, Texas--(BW HealthWire)--July 24, 1998--Medical Carbon Research Institute, LLC (MCRI) announced today that it has obtained CE Mark approval for the On-X Heart Valve prosthesis
These include enabling MRI imaging of heart valve prosthesis
to provide doctors a more effective and less invasive alternative to diagnose heart valve function compared to the currently available invasive techniques, as well as the ability to enable a new generation of MRI-guided implantable stent-based heart valves.
Nasdaq-NNM: ATSI) announced today that the Company has received approval from TUV Product Services of Munich, Germany to apply the Commission Europeen (CE) Mark to the ATS Open Pivot Bileaflet(TM) heart valve prosthesis
and accessory line.
It is well documented that the On-X valve does not produce the turbulence and blood damage commonly produced by other mechanical heart valve prosthesis
and therefore significantly reduces the potential for life-threatening blood clots.
Jude Medical and several academic partners will attempt to develop a tissue-engineered heart valve prosthesis
that once implanted, will attach the patient's own endothelial cells (which line the interior of all blood vessels) and fibroblasts (which synthesize proteins and other extra cellular matrix materials).
Freedom Solo(TM) represented an innovation in the heart valve prosthesis
arena, due to its unique characteristics of being a totally biological valve, virtually identical to the native valve, which can be easily and quickly implanted with a single suture line, giving superior results in terms of haemodynamics.
The first mechanical heart valve prosthesis
using this revolutionary material named Pyrolite(R) Carbon was implanted in 1969.
Jude Medical and ATS Open Pivot Bileaflet Heart Valve Prosthesis
Impact of mechanical heart valve prosthesis
sound on patient's quality of life.
The transapical TAVI system consists of both the Cathlete delivery system and The JenaValve heart valve prosthesis
Recurrent endocarditis in silver-coated heart valve prosthesis
Therapeutic Hematology Market Dynamics - Evolution in Drug Therapies - Growth of Self-Administration - Key Markets for Hematology Drug Therapeutics - Anemia - Deep Vein Thrombosis - Heart Valve Prosthesis
- Neutropenia - Pulmonary Embolism - Competitive Landscape - Opportunities and Risks